|
FAM10A4 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.630090E-04 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.891800E-01 |
| Normal-vs-Stage2 |
3.033800E-02 |
| Normal-vs-Stage3 |
3.93939999999704E-05 |
| Normal-vs-Stage4 |
1.58701999999344E-05 |
| Stage1-vs-Stage2 |
1.306390E-01 |
| Stage1-vs-Stage3 |
6.205700E-04 |
| Stage1-vs-Stage4 |
5.7827999999982E-05 |
| Stage2-vs-Stage3 |
3.458000E-01 |
| Stage2-vs-Stage4 |
1.115180E-01 |
| Stage3-vs-Stage4 |
3.775600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.010000E-04 |
| Normal-vs-AfricanAmerican |
3.29129999998568E-06 |
| Normal-vs-Asian |
3.903900E-03 |
| Caucasian-vs-AfricanAmerican |
1.408430E-02 |
| Caucasian-vs-Asian |
3.316200E-01 |
| AfricanAmerican-vs-Asian |
7.355000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.210060E-04 |
| Normal-vs-Female |
1.195710E-02 |
| Male-vs-Female |
3.353000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.113520E-02 |
| Normal-vs-Age(41-60Yrs) |
3.923200E-03 |
| Normal-vs-Age(61-80Yrs) |
6.048300E-04 |
| Normal-vs-Age(81-100Yrs) |
3.722000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.764990E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.092200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.991200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.690600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.912800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.881000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
7.145000E-01 |
| Normal-vs-Grade 2 |
1.324780E-01 |
| Normal-vs-Grade 3 |
2.076000E-03 |
| Normal-vs-Grade 4 |
2.59449994821637E-09 |
| Grade 1-vs-Grade 2 |
1.904580E-01 |
| Grade 1-vs-Grade 3 |
2.183900E-02 |
| Grade 1-vs-Grade 4 |
2.64890000001294E-06 |
| Grade 2-vs-Grade 3 |
7.209600E-02 |
| Grade 2-vs-Grade 4 |
8.8207999793255E-09 |
| Grade 3-vs-Grade 4 |
1.150920E-04 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
6.891600E-02 |
| Normal-vs-ccB subtype |
1.39870004467468E-10 |
| ccA subtype-vs-ccB subtype |
4.44089209850063E-16 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.206800E-04 |
| Normal-vs-N1 |
1.083980E-03 |
| N0-vs-N1 |
2.279700E-02 |
|
|
